Abstract:Background/Aims: Diabetic cardiomyopathy (DCM) is a common complication of diabetes and can cause heart failure, arrhythmia and sudden death. The pathogenesis of DCM includes altered metabolism, mitochondrial dysfunction, oxidative stress, inflammation, cell death and extracellular matrix remodeling. Recently, pyroptosis, a type of programmed cell death related to inflammation, was proven to be activated in DCM. However, the molecular mechanisms underlying pyroptosis in DCM remain elusive. The long non-coding RNA (lncRNA) Kcnq1ot1 participates in many cardiovascular diseases. This study aims to clarify whether Kcnq1ot1 affects cardiac pyroptosis in DCM. Methods: AC16 cells and primary cardiomyocytes were incubated with 5.5 and 50 mmol/L glucose. Diabetic mice were induced with streptozotocin (STZ). Kcnq1ot1 was silenced both in vitro and in vivo. qRT-PCR was used to detect the expression level of Kcnq1ot1. Immunofluorescence, qRT-PCR and western blot analyses were used to detect the degree of pyroptosis. Echocardiography, hematoxylin and eosin staining, and Masson's trichrome staining were used to detect the cardiac function and morphology in mice. Cell death and function were detected using TUNEL staining, immunofluorescence staining and Ca2+ measurements. Results: The expression of Kcnq1ot1 was increased in patients with diabetes, high glucose-induced cardiomyocytes and diabetic mouse cardiac tissue. Silencing Kcnq1ot1 alleviated pyroptosis by targeting miR-214-3p and caspase-1. Furthermore, silencing Kcnq1ot1 reduced cell death, cytoskeletal structure abnormalities and calcium overload in vitro and improved cardiac function and morphology in vivo. Conclusion: Kcnq1ot1 is overexpressed in DCM, and silencing Kcnq1ot1 inhibits pyroptosis by influencing miR-214-3p and caspase-1 expression. We clarified for the first time that Kcnq1ot1 could be a new therapeutic target for DCM. (C) 2018 The Author(s) Published by S. Karger AG, Basel

Pyroptosis: mechanisms and links with diabetic cardiomyopathy

Role of pyroptosis in diabetic cardiomyopathy: an updated review

New Insights into the Mechanisms of Pyroptosis and Implications for Diabetic Kidney Disease

Pyroptosis and Its Regulation in Diabetic Cardiomyopathy

The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

Research Progress of Pyroptosis in Diabetic Kidney Disease

Pyroptosis: A New Regulating Mechanism in Cardiovascular Disease

Pyroptosis in diabetes and diabetic nephropathy

Ferroptosis, necroptosis and cuproptosis: Novel forms of regulated cell death in diabetic cardiomyopathy

Pyroptosis: Role and Mechanisms in Cardiovascular Disease

Pyroptosis in Diabetic Peripheral Neuropathy and its Therapeutic Regulation

Role of pyroptosis in the pathogenesis and treatment of diseases

Pyroptosis: A pro-inflammatory type of cell death in cardiovascular disease

GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy

Exploring Exercise-Driven Inhibition of Pyroptosis: Novel Insights into Treating Diabetes Mellitus and Its Complications

Research Progress of the Relationship Between Pyroptosis and Disease

Pyroptosis Patterns Are Involved in Immune Microenvironment Regulation of Dilated Cardiomyopathy

LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.

The Role of Pyroptosis in Coronary Heart Disease

Pyroptosis in health and disease: mechanisms, regulation and clinical perspective